PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells

Haiying Cheng, Zhenfeng Zhang, Alain Borczuk, Charles A. Powell, Adayabalam S. Balajee, Howard B. Lieberman, Balazs Halmos

Research output: Contribution to journalArticle

57 Scopus citations

Fingerprint Dive into the research topics of 'PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences